1 Followers SHG:603392 - Beijing Wantai Biological Pharmacy Enterprise Co Ltd

Beijing Wantai Biological Phar
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2013 Q4	2014 Q4	2015 Q4	2016 Q4	2017 Q4	2018 Q2	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	Graph
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	2.16B -	2.19B 1.4%	2.83B 28.9%	3.18B 12.6%	3.53B 10.9%	3.91B 10.6%	4.41B 12.8%	5.49B 24.4%	7.05B 28.4%	9.12B 29.4%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	584.19M -	542.95M -7.1%	682.63M 25.7%	815.86M 19.5%	950.56M 16.5%	1.03B 8.9%	1.21B 16.6%	1.8B 49.1%	2.48B 38.1%	3.17B 27.6%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	1.56B -	1.63B 4.5%	2.12B 30.2%	2.34B 10.5%	2.55B 9.0%	2.84B 11.3%	3.17B 11.4%	3.63B 14.7%	4.47B 22.9%	5.8B 29.8%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	272.68M -	-	356.37M -	-	468.21M -	-	724.97M -	-	1.68B -	-
Investing CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-85.57M -	-198.37M -	-242.1M -	-253.7M -	-237.66M -	-295.4M -	-428.79M -	-528.69M -	-863.23M -	-1.01B -	-1.12B -
Financing CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-2.7M -	-5.18M -	15.42M -	390.37M 2430.9%	379.49M -2.8%	379.79M 0.1%	358.52M -5.6%	-126.59M -	8.28M -	52.79M 537.2%	99.77M 89.0%
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	160.09M -62.5%	88.52M -44.7%	401.35M 353.4%	160.09M -60.1%	143.98M -10.1%	157.87M 9.6%	214.46M 35.8%	653.54M 204.7%	659.1M 0.9%	701.46M 6.4%	587.02M -16.3%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	143.98M -9.6%	157.87M 9.6%	426.61M 170.2%	653.14M 53.1%	662.99M 1.5%	701.46M 5.8%	724.37M 3.3%	723.23M -0.2%	692.43M -4.3%	1.41B 104.1%	1.62B 14.4%
Free CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	20.84M -78.0%	110.68M 431.0%	34.02M -69.3%	80.73M 137.3%	42.45M -47.4%	77.77M 83.2%	65.52M -15.7%	75.65M 15.5%	33.29M -56.0%	634.16M 1804.7%	887.12M 39.9%
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	306.67M -70.9%	1.18B 286.0%	1.24B 5.1%	1.5B 20.9%	1.95B 29.8%	2.35B 20.6%	2.87B 21.8%	3.47B 21.2%	4.35B 25.2%	5.75B 32.2%	8.1B 40.8%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	210.3M -	-	371.98M -	-	681.82M -	-	1.16B -	-	2.08B -	-
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.071 -86.1%	0.386 440.0%	0.441 14.3%	0.657 49.0%	0.964 46.7%	1.157 20.0%	1.005 -13.2%	1.351 34.5%	1.551 14.8%	2.22 43.1%	3.36 51.4%
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	13.05% -48.9%	17.64% 35.2%	19.21% 8.9%	24.45% 27.2%	28.19% 15.3%	28.76% 2.0%	31.24% 8.6%	33.23% 6.4%	32.14% -3.3%	35.15% 9.4%	37.83% 7.6%
Return On Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	14.36% -	14.67% 2.2%	17.34% 18.2%	23.49% 35.5%	32.92% 40.1%	40.06% 21.7%	43.68% 9.0%	46.8% 7.1%	57.59% 23.1%	70.91% 23.1%
Return On Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	10.5% -	10.89% 3.8%	13% 19.3%	17.29% 33.0%	23.89% 38.2%	29.36% 22.9%	31.91% 8.7%	32.26% 1.1%	38.32% 18.8%	47.03% 22.7%